Cargando…
Market Exclusivity of the Originator Drugs in South Korea: A Retrospective Cohort Study
Introduction: Generic entry is a well-known driver of competition and cost containment. Objectives: We aim to measure the market exclusivity of originator drugs and to determine what influences the entry of generics in South Korea. Methods: A list of originator drugs approved by the authority from 2...
Autor principal: | Son, Kyung-Bok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056004/ https://www.ncbi.nlm.nih.gov/pubmed/33889560 http://dx.doi.org/10.3389/fpubh.2021.654952 |
Ejemplares similares
-
Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
por: Son, Kyung-Bok, et al.
Publicado: (2019) -
Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?
por: Son, Kyung-Bok
Publicado: (2022) -
Understanding patient and physician responses to various cost-sharing programs for prescription drugs in South Korea: A multilevel analysis
por: Son, Kyung-Bok, et al.
Publicado: (2022) -
Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?
por: Son, Kyung-Bok
Publicado: (2023) -
Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate
por: Park, Jeewon, et al.
Publicado: (2020)